Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Elucidation of the Oxidative Mechanism Effective in Polycystic Ovary Syndrome: a Randomized Controlled Clinical Study

NCT06826625 is registered in ClinicalTrials.gov with Mardin Artuklu University as lead sponsor.

NCT NCT06826625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06826625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Elucidation of the Oxidative Mechanism Effective in Polycystic Ovary Syndrome: a Randomized Controlled Clinical Study
Lead sponsor
Mardin Artuklu University
Phase
Observational
Overall status
Completed
Start date
January 2, 2021
Completion date
February 1, 2025
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oxidative stress, polycystic ovarian syndrome (pcos)